Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
FEMALE
ID05975359

A Pilot Study Comparing the Interi Manifold and Traditional Surgical Drains in Implant-Based Breast Reconstruction

Led by Stanford University · Updated on 2026-04-13

20

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

S

Stanford University

Lead Sponsor

I

IC Surgical, Inc.

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to compare two surgical drain systems used in patients undergoing implant-based breast reconstruction after mastectomy for breast cancer or genetic risk. The study evaluates the Interi Manifold Drain System, a novel device designed to provide consistent suction and improved fluid management, against the commonly used Jackson Pratt drain. The goal is to assess differences in outcomes such as complication rates, number of drain sites, time to drain removal, fluid volume drained, initiation of tissue expansion, and patient satisfaction. Participants will have bilateral mastectomy followed by immediate implant-based breast reconstruction with a tissue expander. Each breast will be randomly assigned to receive either the Interi manifold drain or the Jackson Pratt drain during surgery. Both drains will remain in place until the output is low enough for removal, typically between 1 and 3 weeks after surgery. Patients will monitor their drain output daily and keep logs while drains are in place. Postoperative follow-ups will occur weekly until drain removal and then monthly as part of routine care, including tissue expansion preparation. Throughout the study, researchers will collect clinical data from weekly follow-ups, monitor complications until the second stage surgery (implant exchange), and assess patient satisfaction using questionnaires at several post-op time points. The total fluid drained and timing of tissue expansion will also be recorded. Safety and device performance will be closely monitored, with participation lasting through the initial surgery and follow-up phases, typically up to six months for key outcome assessments.

CONDITIONS

Brief Title

Assessment of the Interi Manifold in Implant-Based Breast Reconstruction

Who Can Participate

Age: 18Years - 65Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Breast cancer diagnosis or genetic mutation with breast mass
  • Planned bilateral mastectomy
  • Immediate implant-based pre-pectoral breast reconstruction using acellular dermal matrix
  • Female, aged 18 to 65 years
  • Ability and willingness to sign informed consent in English
Not Eligible

You will not qualify if you...

  • Prior or planned radiation therapy to the breast within one year post-surgery
  • Participation in another conflicting investigational study
  • Chemotherapy within 21 days prior or planned during study; recent antiplatelet or anticoagulation therapy
  • Current smoker or illicit drug user
  • Prior allergic reaction to Teflon
  • Pregnancy or nursing
  • Undergoing delayed reconstruction after mastectomy
  • Active HIV, urinary tract infection, or other infection
  • Need for more than one manifold drain per breast
  • Use of investigational products interfering with study endpoints

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery

Duration - 1 day

Participants undergo bilateral mastectomy and immediate implant-based breast reconstruction with placement of either the Interi manifold drain or the Jackson Pratt drain in each breast.

1 surgery day visit

Post-operative Follow-up

Duration - 1 to 3 weeks

Participants receive standard post-operative care with weekly follow-up visits to monitor recovery and drain output. Participants monitor and log drain output daily until drain removal, which typically occurs between 1 to 3 weeks after surgery.

Weekly visits until drain removal (typically 1-3 weeks)

Long-term Monitoring

Duration - Up to 6 months

Participants have monthly follow-up visits as needed for routine tissue expansion and preparation for the second stage surgery to replace tissue expanders with permanent implants, which typically occurs up to 6 months after initial surgery.

Monthly visits as needed

Trial Site Locations

Total: 1 location

1

Stanford Hospital and Clinics

Palo Alto, California, United States, 94304

Actively Recruiting

Loading map...

Research Team

K

Kassandra Carrion

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here